Form 8-K - Current report:
SEC Accession No. 0001193125-21-045802
Filing Date
2021-02-17
Accepted
2021-02-17 07:41:52
Documents
7
Period of Report
2021-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d134776d8k.htm 8-K 28918
2 EX-3.1 d134776dex31.htm EX-3.1 71095
3 EX-3.2 d134776dex32.htm EX-3.2 183725
4 EX-10.1 d134776dex101.htm EX-10.1 373734
5 EX-10.2 d134776dex102.htm EX-10.2 198489
6 EX-10.3 d134776dex103.htm EX-10.3 163274
7 EX-10.4 d134776dex104.htm EX-10.4 87021
  Complete submission text file 0001193125-21-045802.txt   1107628
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 21642660
SIC: 3841 Surgical & Medical Instruments & Apparatus